The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 03, 2021

Filed:

Jun. 03, 2016
Applicant:

Joslin Diabetes Center, Inc., Boston, MA (US);

Inventors:

Yu-Hua Tseng, Newton, MA (US);

Matthew Lynes, Brookline, MA (US);

Ruidan Xue, Shanghai, CN;

Assignee:

Joslin Diabetes Center, Inc., Boston, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 35/35 (2015.01); A61K 38/17 (2006.01); A61K 38/46 (2006.01); C12N 5/077 (2010.01); C07K 14/705 (2006.01); A61K 35/545 (2015.01); A61K 31/7088 (2006.01); C12N 15/11 (2006.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 31/7088 (2013.01); A61K 35/35 (2013.01); A61K 35/545 (2013.01); A61K 38/177 (2013.01); A61K 38/1719 (2013.01); A61K 38/1761 (2013.01); A61K 38/1796 (2013.01); A61K 38/465 (2013.01); C07K 14/705 (2013.01); C12N 5/0653 (2013.01); C12N 15/11 (2013.01); C12Q 1/6883 (2013.01); C12Y 301/03048 (2013.01); G01N 33/5091 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01); C12N 2310/20 (2017.05); C12N 2800/80 (2013.01); C12Q 2600/118 (2013.01);
Abstract

The invention provides methods and compositions relating to molecular targets identified as being capable of increasing or decreasing thermogenic potential in cells, including preadipocytes. Included in the invention are methods and compositions relating to inhibiting or suppressing the activity of an uncoupling protein 1 (UCP1) negative regulator, such as cardiac actin 1 (ACTC1), somatostatin receptor 1 (SSTR1), FAT atypical cadherin 1 (FAT1), and protein tyrosine phosphatase receptor type B (PTPRB). Also included in the invention are methods and compositions relating to activating a UCP1 positive regulator, such as phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1), cortactin binding protein 2 (CTTNBP2), doublesex and mab-3-related transcription factor-like family A1 (DMRTA1), and endothelin receptor type B (ENDRB). The invention also provides methods and compositions relating to enrichment of cells having thermogenic potential based on cell surface markers, e.g., CD29, identified as being predictive of such.


Find Patent Forward Citations

Loading…